Table 3. Details of the seven cases of definitive malignant transformation of PK into skin cancer.
Porokeratosis | Malignant Transformation | |||||||||
Age of dx (yrs) | Type | Type of treatment | Age of dx (yrs) | Duration of PK at time of MT (yrs) | Location | Type of skin cancer | Evidence of MT | Number of other skin cancers | Immune suppression | Radiation therapy |
73 | DSAP | None | 77 | 4 | LE | SCCIS | Histologic confirmation | 10 | no | no |
11 | Linear | Cryotherapy, tazarotene | 62 | 51 | LE | SCC | Histologic confirmation | 1 | no | no |
71 | PM | None | 75 | 4 | LE | SCC | By photograph and clinical description** | 1 | no | no |
50 | Linear | None | 62 | 12 | UE | SCC | By clinical description** | 4 | yes | yes |
41 | DSAP | Tretinoin 0.05% | 41 | 0* | LE | SCCIS | Histologic confirmation | 3 | no | no |
72 | PM | Silvadene cream and clobetasol | 85 | 13 | LE | SCC | By clinical description** | 2 | yes | no |
55 | DSAP | 5-fluorouracil | 51 | 0* | UE | SCCIS | By clinical description** | 14 | yes | yes |